GE HEALTHCARE TECHNOLOGIES INC(GEHC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GEHC GE HEALTHCARE TECHNOLOGIES INC

盘前交易 09-14 06:12:21 EDT

63.93

-0.31

-0.48%

盘前64.00

+0.07+0.11%

06:00 EDT

最高65.40	最低63.22	成交量319.85万
今开64.96	昨收64.24	日振幅3.39%
总市值288.76亿	流通市值288.76亿	总股本4.52亿
成交额2.04亿	换手率0.71%	流通股本4.52亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GEHC","market":"US","secType":"STK","nameCN":"GE HEALTHCARE TECHNOLOGIES INC","latestPrice":63.93,"timestamp":1789156800000,"preClose":64.24,"halted":0,"volume":3198490,"hourTrading":{"tag":"盘前","latestPrice":64,"preClose":63.93,"latestTime":"06:00 EDT","volume":551,"amount":35446.83833,"timestamp":1789380014777,"change":0.07,"changeRate":0.001095,"amplitude":0.011575},"delay":0,"changeRate":-0.004825653798256463,"floatShares":451686252,"shares":451686252,"eps":4.340131,"marketStatus":"盘前交易","change":-0.31,"latestTime":"09-14 06:12:21 EDT","open":64.96,"high":65.4,"low":63.22,"amount":203983693.35301998,"amplitude":0.033935,"askPrice":64.5,"askSize":2,"bidPrice":63.29,"bidSize":70,"shortable":3,"etf":0,"ttmEps":4.340131,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789392600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":63.93,"dividendRate":0.00219,"preHourTrading":{"tag":"盘前","latestPrice":64,"preClose":63.93,"latestTime":"06:00 EDT","volume":551,"amount":35446.83833,"timestamp":1789380014777,"change":0.07,"changeRate":0.001095,"amplitude":0.011575},"postHourTrading":{"tag":"盘后","latestPrice":64.16,"preClose":63.93,"latestTime":"19:48 EDT","volume":267624,"amount":17109408.6043,"timestamp":1789170518680,"change":0.23,"changeRate":0.003598,"amplitude":0.004693},"volumeRatio":1.0052767986739535,"impliedVol":0.3069,"impliedVolPercentile":0.324},"requestUrl":"/m/hq/s/GEHC","defaultTab":"news","newsList":[{"id":"1105426520","title":"GE医疗携Starguide™ Gx 4D SPECT/CT推动诊疗一体化新时代，510(k)申请已递交美国FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=1105426520","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105426520?lang=zh_cn&edition=full","pubTime":"2026-09-08 20:02","pubTimestamp":1788868944,"startTime":"0","endTime":"0","summary":"GE医疗正致力于开启诊疗一体化（Theranostics）的新篇章，其Starguide™ Gx 4D SPECT/CT系统现已向美国FDA提交510(k)上市前通告，目前处于待批状态。这一举措标志着该公司在精准医疗领域的又一次重要布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GEHC","LU0124676726.USD","BK4585","BK4588","LGHT","LU0689626769.HKD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122019840","title":"Trian Fund Management 披露2026年第二季度持仓变动，与上季度相比有何变化？","url":"https://stock-news.laohu8.com/highlight/detail?id=1122019840","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122019840?lang=zh_cn&edition=full","pubTime":"2026-08-13 04:56","pubTimestamp":1786568169,"startTime":"0","endTime":"0","summary":"Trian Fund Management, L.p. 公布了截至2026年6月30日的持仓变动情况。此次披露的数据，与截至2026年3月31日的上一季度末持仓状况进行了对比。这些变化反映出该基金在相关资产上的新配置与调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","IE00B64PRP62.GBP","BK4585","LU0689626769.HKD","LGHT","IE00BGHQF748.EUR","LU0124676726.USD","GEHC","BK4135","IVZ","IE00B3QW5Z07.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102086120","title":"Trian基金管理公司增持GE HealthCare Technologies Inc.股份至310万股——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1102086120","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102086120?lang=zh_cn&edition=full","pubTime":"2026-08-13 04:52","pubTimestamp":1786567929,"startTime":"0","endTime":"0","summary":"Trian Fund Management, L.p. 近日通过一份提交给美国证券交易委员会（SEC）的文件对外披露，已将其在GE Healthcare Technologies Inc.（以下简称“GE HealthCare”）的持股规模提升至310万股。这一显著的增持动作，反映出该知名对冲基金对这家医疗科技巨头未来发展前景的持续看好。市场分析人士认为，此举可能预示着投资者对医疗健康领域，尤其是大型设备与技术解决方案的长期信心正在增强。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","BK4082","LU0689626769.HKD","BK4588","LGHT","GEHC","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154606127","title":"GE HealthCare 考虑为陷入困境的业务部门探索战略选择","url":"https://stock-news.laohu8.com/highlight/detail?id=1154606127","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154606127?lang=zh_cn&edition=full","pubTime":"2026-07-29 22:14","pubTimestamp":1785334447,"startTime":"0","endTime":"0","summary":"美国东部时间上午10点10分——GE HealthCare Technologies（GEHC）公布第二季度营收为53亿美元，同比增长5.8%，这一成绩超出了华尔街预期。在与分析师的电话会议上，CEO Peter Arduini 将增长归功于公司制药诊断部门以及先进成像解决方案业务的强劲表现。他指出：“患者护理解决方案的表现依然面临挑战。尽管我们致力于让该业务重返增长与盈利轨道，但我们正在评估各种战略选项，以最大化其长期价值。”受医疗科技公司最近季度调整后每股收益高于预期的提振，GE HealthCare（GEHC）股价大涨12%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","LU1066053197.SGD","GEHC","LU0077335932.USD","LU1280957306.USD","UXI","LU0354030438.USD","LU1066051498.USD","LU1366333091.USD","LU1551013342.USD","LU1066051811.HKD","LU2543165471.USD","DFEN","BK4187","LU1551013425.SGD","LU0149725797.USD","BK4543","TRUI","MISL","LU0267386448.USD","LU2756315664.SGD","BK4206","LU0640476718.USD","LU0354030511.USD","XAR","LU1064131342.USD","BK4082","LU0820562030.AUD","LU1261432733.SGD","BK4585","LU1093756168.USD","LU2168564222.USD","BK4588","EXI","LU2168564495.EUR","LU1119994496.HKD","ITA","LU1084165304.USD","LU2756315318.SGD","LU2168563687.JPY","NATO","LU0820561818.USD","LU1066051225.USD","LU2264538146.SGD","LU0689472784.USD","LU1988902786.USD","BK4566","GE","LU0820561909.HKD","LU2087625088.SGD","PPA","LGHT","LU1093756325.SGD","LU0157215616.USD","LU0353189680.USD","LU0689626769.HKD","LU1366192091.USD","LU2168564149.EUR","LU2168564065.EUR","LU0943347566.SGD","LU0868494617.USD","LU0353189763.USD","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144811467","title":"异动解读｜GE医疗盘中上涨7.46%，Q2盈利超预期叠加全年指引重申","url":"https://stock-news.laohu8.com/highlight/detail?id=1144811467","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144811467?lang=zh_cn&edition=full","pubTime":"2026-07-29 21:31","pubTimestamp":1785331903,"startTime":"0","endTime":"0","summary":"7月29日，GE医疗盘中上涨7.46%，报69.34美元/股，成交额5528.77万美元。消息面上，公司于当日发布第二季度财报，调整后每股收益1.13美元，显著优于市场预期的1.04美元，净收入达5.61亿美元。同时公司重申全年调整后每股收益指引区间为4.80至5.00美元，与一致预期基本吻合。此前公司在一季度因内存芯片、石油及运费成本激增曾下调全年EPS指引，本次重申表明成本压力已得到有效管控。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GEHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125864649","title":"GE医疗高管：预计2026下半年患者护理解决方案板块供应改善，将利好销售与利润率","url":"https://stock-news.laohu8.com/highlight/detail?id=1125864649","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125864649?lang=zh_cn&edition=full","pubTime":"2026-07-29 20:49","pubTimestamp":1785329386,"startTime":"0","endTime":"0","summary":"GE HEALTHCARE TECHNOLOGIES INC（简称GE医疗）高管在电话会议中透露，公司预期患者护理解决方案板块的供应状况将在2026年下半年得到改善。这一积极变化，预计将同时推动该领域的销售业绩和利润率实现双增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689626769.HKD","BK4082","BK4585","GEHC","LU0124676726.USD","BK4588","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189451083","title":"GE医疗高管表示：聚焦人工智能，提升生产力、简化工作、强化供应链——电话会议实录","url":"https://stock-news.laohu8.com/highlight/detail?id=1189451083","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189451083?lang=zh_cn&edition=full","pubTime":"2026-07-29 20:41","pubTimestamp":1785328871,"startTime":"0","endTime":"0","summary":"在最近一次电话会议上，GE医疗（GE HEALTHCARE TECHNOLOGIES INC）的一位高管明确表态：公司将重心放在利用人工智能技术之上。其核心目标，在于全方位提升生产力。同时，他们也致力于简化工作流程。不仅如此，AI还将被用来巩固供应链的韧性。这一系列举措，旨在为公司的长远发展注入强劲动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689626769.HKD","BK4082","LGHT","BK4588","BK4585","LU0124676726.USD","GEHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103631026","title":"GE医疗第二季度调整后每股收益1.13美元，优于预期的1.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1103631026","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103631026?lang=zh_cn&edition=full","pubTime":"2026-07-29 18:44","pubTimestamp":1785321840,"startTime":"0","endTime":"0","summary":"GE医疗（GE HEALTHCARE TECHNOLOGIES INC）第二季度财报出炉。数据显示，公司净收入达到5.61亿美元。与此同时，其调整后每股收益为1.13美元，这一数字明显高于市场普遍预期的1.04美元，显示出公司强劲的盈利能力和运营表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689626769.HKD","BK4588","GEHC","LGHT","BK4082","BK4585","LU0124676726.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162529745","title":"异动解读 | GE医疗盘前大涨5.76%，Q2财报发布重申全年盈利指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1162529745","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162529745?lang=zh_cn&edition=full","pubTime":"2026-07-29 18:33","pubTimestamp":1785321181,"startTime":"0","endTime":"0","summary":"GE医疗今日盘前股价大涨5.76%，报69.5美元/股，引发了市场的广泛关注。消息面上，公司于盘前发布第二季度财报，并重申全年调整后每股收益指引区间为4.80至5.00美元，与FactSet一致预期4.88美元基本吻合。本次重申指引表明成本压力已得到有效管控，业务延续稳健增长态势。公司此前已于7月24日提前披露Q2初步业绩，传递出业务加速的积极信号。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GEHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161856219","title":"GE医疗重组计划：预计未来12个月内产生额外费用3800万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1161856219","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161856219?lang=zh_cn&edition=full","pubTime":"2026-07-29 18:32","pubTimestamp":1785321130,"startTime":"0","endTime":"0","summary":"GE医疗（GE HEALTHCARE TECHNOLOGIES INC）宣布，其重组计划预计将衍生出约3800万美元的额外费用。这些支出主要将在接下来的12个月内逐步落实。这笔费用，不仅反映了公司对运营架构的深度调整，也凸显了其精简业务流程、提升效率的决心。尽管短期内财务压力显现，但此举被视作长期战略的一部分，旨在优化资源配置，并为未来增长铺平道路。随着重组措施的推进，GE医疗将密切关注成本控制，力求在过渡期内平衡财务表现与业务转型。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0689626769.HKD","LGHT","BK4585","LU0124676726.USD","GEHC","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142968600","title":"GE医疗：截至6月30日收到1.07亿美元退款，已提交但未报销的索赔入账3800万应收款——文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1142968600","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142968600?lang=zh_cn&edition=full","pubTime":"2026-07-29 18:29","pubTimestamp":1785320951,"startTime":"0","endTime":"0","summary":"根据最新文件显示，GE HEALTHCARE TECHNOLOGIES INC（GE医疗）在截至6月30日已成功收回1.07亿美元的退款。不仅如此，公司还记录了一笔3800万美元的应收款项，这些款项对应的是已提交但尚未获得报销的索赔申请。这一财务动态反映出公司在现金流管理和应收账款处理上的最新进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU0689626769.HKD","GEHC","BK4588","LGHT","BK4585","LU0124676726.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165488435","title":"异动解读｜GE医疗盘前上涨5.76%，Q2财报发布重申全年盈利指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1165488435","media":"行情直击","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165488435?lang=zh_cn&edition=full","pubTime":"2026-07-29 18:25","pubTimestamp":1785320707,"startTime":"0","endTime":"0","summary":"7月29日，GE医疗盘前上涨5.76%，报69.5美元/股，成交额10.8万美元。消息面上，公司于盘前发布第二季度财报，并重申全年调整后每股收益指引区间为4.80至5.00美元，与FactSet一致预期4.88美元基本吻合。此前公司在一季度因内存芯片、石油及运费成本激增，将全年调整后EPS指引从4.95-5.15美元下调至4.80-5.00美元，当时股价承压。本次重申指引表明成本压力已得到有效管控，业务延续稳健增长态势。公司7月24日已提前披露Q2初步业绩，传递业务加速信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GE医疗Q2财报发布重申全年盈利指引","news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GEHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126337382","title":"GE医疗宣布首席财务官变动，发布2026年第二季度初步业绩并重申指引，彰显业务强劲势头","url":"https://stock-news.laohu8.com/highlight/detail?id=1126337382","media":"美股速递","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126337382?lang=zh_cn&edition=full","pubTime":"2026-07-24 04:17","pubTimestamp":1784837828,"startTime":"0","endTime":"0","summary":"GE医疗（GE HEALTHCARE TECHNOLOGIES INC）正式公布首席财务官（CFO）的过渡计划。与此同时，公司还披露了2026年第二季度的初步财务数据，并重申了全年业绩指引。这一切举措，都传递出业务正持续加速前行的积极信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0689626769.HKD","BK4585","BK4082","GEHC","LGHT","LU0124676726.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168754533","title":"财报前瞻｜GE HEALTHCARE TECHNOLOGIES INC营收预计增6.01%，机构偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1168754533","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168754533?lang=zh_cn&edition=full","pubTime":"2026-07-22 10:02","pubTimestamp":1784685748,"startTime":"0","endTime":"0","summary":"GE HEALTHCARE TECHNOLOGIES INC将于2026年07月29日发布新一季财报，市场关注营收与利润率改善节奏及成本压力变化。发展前景较为明确的存量业务为成像板块，上季营收22.99亿美元，占比44.81%，叠加公司整体营收同比增长7.41%，硬件升级与AI功能迭代共同支撑产品组合上行。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜GE HEALTHCARE TECHNOLOGIES INC营收预计增6.01%，机构偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GEHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178688255","title":"异动解读｜GE医疗盘中下跌6.29%，报61.2美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178688255","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178688255?lang=zh_cn&edition=full","pubTime":"2026-07-15 00:15","pubTimestamp":1784045754,"startTime":"0","endTime":"0","summary":"7月14日，GE医疗盘中下跌6.29%，报61.2美元/股，成交额2.75亿美元。GE医疗所在的医疗保健设备行业整体承压，个股中，直觉外科公司跌6.57%，史赛克跌6.52%，波士顿科学跌4.23%，雅培跌2.9%，美敦力跌4.83%。GE HealthCare Technologies Inc.是全球领先的医疗解决方案提供商，提供先进的医疗技术、药物诊断以及人工智能云和软件解决方案，服务覆盖超过160个国家的客户。公司下次财报将于7月29日盘前发布，预期每股收益1.04美元。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GEHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101778527","title":"GE医疗与梅奥诊所携手推进新型诊疗一体化研究合作 旨在革新个性化癌症治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1101778527","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101778527?lang=zh_cn&edition=full","pubTime":"2026-07-08 21:02","pubTimestamp":1783515727,"startTime":"0","endTime":"0","summary":"GE医疗与梅奥诊所宣布建立一项新的诊疗一体化研究合作关系，双方共同致力于推动个性化癌症治疗领域的进步。\n此次合作将聚焦于诊疗一体化领域，这是一种将诊断与靶向治疗相结合的前沿医疗模式。双方旨在通过整合GE医疗在成像技术、药物发现与数据分析方面的专长，以及梅奥诊所世界级的临床研究能力与患者护理经验，加速开发更精准、有效的癌症治疗方案。\n该合作伙伴关系期望能推动针对特定癌症类型的创新疗法研发，最终目标是为患者提供高度个性化的治疗选择，从而改善治疗效果并提升患者生活质量。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","BK4082","LU0689626769.HKD","LGHT","GEHC","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189041437","title":"FDA发布早期预警：通用电气医疗婴儿复苏系统存潜在高风险","url":"https://stock-news.laohu8.com/highlight/detail?id=1189041437","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189041437?lang=zh_cn&edition=full","pubTime":"2026-06-06 02:54","pubTimestamp":1780685652,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）下属的器械与放射健康中心（CDRH）发布了一项早期预警，旨在向公众通报通用电气医疗（GE Healthcare）旗下婴儿复苏系统可能存在的潜在高风险问题。该警示要求相关方提高警惕，并关注后续的官方安全通告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689626769.HKD","BK4082","BK4585","GEHC","LU0124676726.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167179961","title":"GE Healthcare获FDA 510(k)许可推出Mim Contour ProtÉGÉAI+ 2.0，拓展临床能力推进AI赋能放疗规划","url":"https://stock-news.laohu8.com/highlight/detail?id=1167179961","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167179961?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:59","pubTimestamp":1780574357,"startTime":"0","endTime":"0","summary":"GE Healthcare Technologies Inc  宣布，其Mim Contour ProtGAI+ 2.0已获得美国食品药品监督管理局的510许可。这一进展标志着该公司在人工智能驱动的放射治疗规划领域迈出了重要一步，新版本带来了显著扩展的临床功能。此次升级旨在通过增强的AI工具优化治疗流程，提升精度与效率。随着医疗AI应用的不断深入，GE Healthcare此次获批进一步巩固了其在放射治疗解决方案市场的地位。该产品有望帮助医疗机构缩短规划时间，改善患者治疗效果，推动精准肿瘤治疗的发展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU0689626769.HKD","GEHC","BK4585","LU0124676726.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141182902","title":"2026年欧洲放射治疗与肿瘤学会年会：GE医疗将重点展示AI赋能解决方案，推动放射治疗与影像引导介入领域的精准医疗发展","url":"https://stock-news.laohu8.com/highlight/detail?id=1141182902","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141182902?lang=zh_cn&edition=full","pubTime":"2026-05-12 21:01","pubTimestamp":1778590875,"startTime":"0","endTime":"0","summary":"在即将举行的2026年欧洲放射治疗与肿瘤学会（ESTRO）年会上，GE医疗技术公司计划重点推介其人工智能赋能的创新解决方案。这些方案旨在显著提升放射治疗与影像引导介入治疗两大关键领域的精准医疗水平。通过展示前沿技术，GE医疗期望推动肿瘤诊疗的个性化与精确度迈向新台阶。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GEHC","BK4588","LU0689626769.HKD","BK4585","LU0124676726.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126155996","title":"GE医疗首席财务官詹姆斯·萨卡罗申报于5月1日以每股60.5997美元均价公开市场购入3310股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1126155996","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126155996?lang=zh_cn&edition=full","pubTime":"2026-05-01 23:48","pubTimestamp":1777650503,"startTime":"0","endTime":"0","summary":"根据最新提交的美国证券交易委员会（SEC）文件披露，GE Healthcare Technologies Inc（GEHC）首席财务官詹姆斯·萨卡罗于5月1日在公开市场完成一笔股票交易。记录显示，萨卡罗以每股60.5997美元的平均价格，合计购入3310股公司普通股。\n此次交易通过公开市场操作执行，凸显了公司管理层对GE医疗未来增长前景的信心。公开市场购买行为往往被投资者视为内部人士看好企业价值的积极信号。\n根据监管规定，上市公司高管及董事的股权交易需及时向SEC报备，以确保市场信息的透明度和公平性。此次交易细节已通过正式文件向监管机构报备。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689626769.HKD","BK4082","BK4588","BK4585","LU0124676726.USD","GEHC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://gehealthcare.com;investor.gehealthcare.com","stockEarnings":[{"period":"1week","weight":-0.0716},{"period":"1month","weight":-0.1155},{"period":"3month","weight":-0.0192},{"period":"6month","weight":-0.0967},{"period":"1year","weight":-0.18},{"period":"ytd","weight":-0.2206}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GE HealthCare Technologies Inc.于2022年5月16日作为特拉华州有限责任公司成立。该公司是全球领先的医疗解决方案提供商，提供先进的医疗技术、药物诊断以及人工智能云和软件解决方案。其服务覆盖超过160个国家的客户，致力于提供旨在实现更个性化和精准患者护理的创新技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.013681},{"month":2,"riseRate":0.75,"avgChangeRate":0.09846},{"month":3,"riseRate":0.25,"avgChangeRate":-0.039015},{"month":4,"riseRate":0,"avgChangeRate":-0.110914},{"month":5,"riseRate":0.75,"avgChangeRate":0.007057},{"month":6,"riseRate":0.75,"avgChangeRate":0.024391},{"month":7,"riseRate":0.5,"avgChangeRate":0.017938},{"month":8,"riseRate":0.75,"avgChangeRate":-0.003392},{"month":9,"riseRate":0.5,"avgChangeRate":-0.002913},{"month":10,"riseRate":0,"avgChangeRate":-0.030954},{"month":11,"riseRate":0.666667,"avgChangeRate":0.016118},{"month":12,"riseRate":0.666667,"avgChangeRate":0.031412}],"exchange":"NASDAQ","name":"GE HEALTHCARE TECHNOLOGIES INC","nameEN":"GE HEALTHCARE TECHNOLOGIES INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GE HEALTHCARE TECHNOLOGIES INC(GEHC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GE HEALTHCARE TECHNOLOGIES INC(GEHC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GE HEALTHCARE TECHNOLOGIES INC,GEHC,GE HEALTHCARE TECHNOLOGIES INC股票,GE HEALTHCARE TECHNOLOGIES INC股票老虎,GE HEALTHCARE TECHNOLOGIES INC股票老虎国际,GE HEALTHCARE TECHNOLOGIES INC行情,GE HEALTHCARE TECHNOLOGIES INC股票行情,GE HEALTHCARE TECHNOLOGIES INC股价,GE HEALTHCARE TECHNOLOGIES INC股市,GE HEALTHCARE TECHNOLOGIES INC股票价格,GE HEALTHCARE TECHNOLOGIES INC股票交易,GE HEALTHCARE TECHNOLOGIES INC股票购买,GE HEALTHCARE TECHNOLOGIES INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GE HEALTHCARE TECHNOLOGIES INC(GEHC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GE HEALTHCARE TECHNOLOGIES INC(GEHC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}